Investing Profile
Heath Lukatch
VCInvestorFounder
Founder & Managing Partner at Red Tree Venture Capital
redtreevc.com/team/San Francisco, California
Your Intro Paths to Heath Lukatch
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Find Heath Lukatch on
cbCurrent Investing Position
Red Tree Venture Capital Managing Partner
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
24
Heath Lukatch is on these Sector & Stage Rankings
Therapeutics (Pre-seed)Pharmaceuticals (Pre-seed)Therapeutics (Seed)Therapeutics (Pre-seed)Pharmaceuticals (Pre-seed)Digital Health (Pre-seed)Pharmaceuticals (Seed)Therapeutics (Seed)Consumer Health (Pre-seed)Health & Hospital Services (Pre-seed)BioTech (Pre-seed)Health IT (Pre-seed)Consumer Health (Seed)Digital Health (Seed)Health & Hospital Services (Pre-seed)Digital Health (Pre-seed)Consumer Health (Pre-seed)Pharmaceuticals (Seed)BioTech (Pre-seed)Health & Hospital Services (Seed)BioTech (Seed)Health IT (Pre-seed)Health IT (Seed)Consumer Health (Seed)BioTech (Seed)Digital Health (Seed)Health IT (Seed)Health & Hospital Services (Seed)San Francisco Bay Area
Heath Lukatch's Investments On Record (19)
| Company | StageDateRound Size | Total Raised |
|---|---|---|
Engrail Therapeutics | Series BMar 2024$160M | $160M |
Tachyon Therapeutics | Series AMar 2023$12M | $12M |
Alladapt Immunotherapeutics | Series UnknownJun 2022$120M | $230M |
Magnus Medical | Series AOct 2021$25M  | $25M |
Acrigen Biosciences | SeedSep 2021 | |
ViaCyte | Series DNov 2018$80M | $140M |
Halo Neuroscience | Series BJan 2018$13M | $24M |
Engage Therapeutics | Series ASep 2017$24M | $24M |
Heath Lukatch's Media (1)
Investors who invest with Heath Lukatch